149 related articles for article (PubMed ID: 32508460)
1. Immunohistochemical detection of Tyrosine Kinase receptor (TrK) in follicular and plexiform ameloblastoma - A novel study.
Jisha GB; Ilayaraja V; Yoithapprabhunath TR; Ganapathy N; Dineshshankar J; Nirmal RM
J Oral Maxillofac Pathol; 2020; 24(1):125-130. PubMed ID: 32508460
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Detection of Nerve Growth Factor (NGF) in Follicular and Plexiform Ameloblastoma - A Novel Study.
Yoithapprabhunath TR; Renugadevi S; Ganapathy N; Dineshshankar J; Yamunadevi A; Nirmal RM
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S569-S575. PubMed ID: 33149523
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of Nuclear Factor-kappa B (NF-κB) between follicular and plexiform ameloblastomas: A pilot study.
Sivakumar M; Yoithapprabhunath TR; Nirmal RM; Veeravarmal V; Dineshshankar J; Amsaveni R
J Oral Maxillofac Pathol; 2020; 24(3):466-471. PubMed ID: 33967482
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Detection of p75 Neurotrophin Receptor (p75-NTR) in Follicular and Plexiform Ameloblastoma.
Ragunathan YT; Madhavan NR; Mohan SP; Kumar SK
J Clin Diagn Res; 2016 Aug; 10(8):ZC63-6. PubMed ID: 27656566
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors.
Kumar H; Vandana R; Kumar G
J Oral Maxillofac Pathol; 2011 Sep; 15(3):283-7. PubMed ID: 22144830
[TBL] [Abstract][Full Text] [Related]
6. Comparison of proliferating cell nuclear antigen expression in odontogenic keratocyst and ameloblastoma: an immunohistochemical study.
Takahashi H; Fujita S; Yamabe S; Moriishi T; Okabe H; Tajima Y; Mizuno A
Anal Cell Pathol; 1998; 16(4):185-92. PubMed ID: 9762365
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of IP3R and V-ATPase in Ameloblastomas.
Giovanini AF; Priesnitz TF; Til B; Reisdoerfer G; do Nascimento TCL; Sobreiro B; de Siqueira AS; Pinheiro JJV
Head Neck Pathol; 2020 Jun; 14(2):392-398. PubMed ID: 31183746
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
10. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
12. Histochemistry of Ki-67 antigen in ameloblastomas.
Nagao Y; Wato M; Tanaka A
J Osaka Dent Univ; 1999 Oct; 33(2):53-7. PubMed ID: 10863475
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma.
Farhan F; Niazi Z; Masood S; Abbas B
Pak J Med Sci; 2022; 38(1):207-213. PubMed ID: 35035427
[TBL] [Abstract][Full Text] [Related]
15. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
16. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
Kumamoto H; Takahashi N; Ooya K
J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of alpha 1-antitrypsin, alpha 1-antichymotrypsin, transferrin and ferritin in ameloblastoma.
Takahashi H; Tsuda N; Yamabe S; Fujita S; Okabe H
Anal Cell Pathol; 1995 Sep; 9(2):135-50. PubMed ID: 7492517
[TBL] [Abstract][Full Text] [Related]
18. Comparative morphometric study of AgNORs in variants of ameloblastoma.
Jain VK; Uma K; Soundarya N; Sangeetha R; Smitha T
J Oral Maxillofac Pathol; 2012 Sep; 16(3):354-8. PubMed ID: 23248466
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: An institutional study.
Shirsat PM; Bansal S; Prasad P; Desai RS
J Oral Maxillofac Pathol; 2018; 22(3):353-359. PubMed ID: 30651680
[TBL] [Abstract][Full Text] [Related]
20. IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS.
Khalil E; Rehman A; Ahmed F
J Ayub Med Coll Abbottabad; 2015; 27(2):296-303. PubMed ID: 26411101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
